title: Is self-administration of subcutaneous immunoglobulin therapy safe in a home care setting?
abstract: Clinical practice based on best evidence can help ensure that patients receive safe and appropriate care from nurses. Members of a nursing inquiry council at a pediatric-based organization addressed the issue of patient-administered immunoglobulin therapy in the home care setting through conducting an evidence-based practice (EBP) project. Following the steps of EBP, an EBP change was implemented that allowed families the option of immunoglobulin therapy administration by the patient (or a caregiver) or a home healthcare nurse. Outcomes measured indicated that self-administration positively impacted patient and family satisfaction and posed no additional safety risks.
authors: Home Health Agency, Division of Home Health Services, Cincinnati Children's Hospital, Cincinnati, OH, USA. lynn.lednik@cchmc.org
authors: Lynn
authors: L
authors: Lednik
authors: Mary
authors: M
authors: Baker
authors: Karen
authors: K
authors: Sullivan
authors: Marilyn
authors: M
authors: Poynter
authors: Lucy
authors: L
authors: OʼQuinn
authors: Carolyn
authors: C
authors: Smith
mesh_terms: D017028:Caregivers; D006699:Home Care Services; D006701:Home Nursing / Q000379:methods; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects / Q000379:methods*; D055104:Infusions, Subcutaneous / Q000009:adverse effects / Q000379:methods; D012646:Self Administration / Q000009:adverse effects / Q000379:methods